These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 19759824)

  • 1. Glutamic acid decarboxylase-derived epitopes with specific domains expand CD4(+)CD25(+) regulatory T cells.
    Chen G; Han G; Feng J; Wang J; Wang R; Xu R; Shen B; Qian J; Li Y
    PLoS One; 2009 Sep; 4(9):e7034. PubMed ID: 19759824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular profile of the T cell receptors of regulatory and effector CD4+ T cells recognizing overlapping determinants on glutamic acid decarboxylase (524-543).
    Im JS; Quinn A; Sercarz EE; Lake DF
    Mol Immunol; 2004 Feb; 40(13):971-80. PubMed ID: 14725793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulatory and effector CD4 T cells in nonobese diabetic mice recognize overlapping determinants on glutamic acid decarboxylase and use distinct V beta genes.
    Quinn A; McInerney B; Reich EP; Kim O; Jensen KP; Sercarz EE
    J Immunol; 2001 Mar; 166(5):2982-91. PubMed ID: 11207247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The type and frequency of immunoregulatory CD4+ T-cells govern the efficacy of antigen-specific immunotherapy in nonobese diabetic mice.
    Pop SM; Wong CP; He Q; Wang Y; Wallet MA; Goudy KS; Tisch R
    Diabetes; 2007 May; 56(5):1395-402. PubMed ID: 17317763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A sudden decline in active membrane-bound TGF-beta impairs both T regulatory cell function and protection against autoimmune diabetes.
    Gregg RK; Jain R; Schoenleber SJ; Divekar R; Bell JJ; Lee HH; Yu P; Zaghouani H
    J Immunol; 2004 Dec; 173(12):7308-16. PubMed ID: 15585854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retroviral delivery of GAD-IgG fusion construct induces tolerance and modulates diabetes: a role for CD4+ regulatory T cells and TGF-beta?
    Song L; Wang J; Wang R; Yu M; Sun Y; Han G; Li Y; Qian J; Scott DW; Kang Y; Soukhareva N; Shen B
    Gene Ther; 2004 Oct; 11(20):1487-96. PubMed ID: 15343360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased entry into the IFN-gamma effector pathway by CD4+ T cells selected by I-Ag7 on a nonobese diabetic versus C57BL/6 genetic background.
    Koarada S; Wu Y; Ridgway WM
    J Immunol; 2001 Aug; 167(3):1693-702. PubMed ID: 11466393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulatory T cell phenotype and function 4 years after GAD-alum treatment in children with type 1 diabetes.
    Pihl M; Akerman L; Axelsson S; Chéramy M; Hjorth M; Mallone R; Ludvigsson J; Casas R
    Clin Exp Immunol; 2013 Jun; 172(3):394-402. PubMed ID: 23600827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclophosphamide-induced type-1 diabetes in the NOD mouse is associated with a reduction of CD4+CD25+Foxp3+ regulatory T cells.
    Brode S; Raine T; Zaccone P; Cooke A
    J Immunol; 2006 Nov; 177(10):6603-12. PubMed ID: 17082572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of type 1 diabetes by a new MHC II-peptide chimera: "Single-epitope-mediated suppression" to stabilize a polyclonal autoimmune T-cell process.
    Lin M; Stoica-Nazarov C; Surls J; Kehl M; Bona C; Olsen C; Brumeanu TD; Casares S
    Eur J Immunol; 2010 Aug; 40(8):2277-88. PubMed ID: 20540111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulation of α7 nicotinic acetylcholine receptor by nicotine increases suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro.
    Wang DW; Zhou RB; Yao YM; Zhu XM; Yin YM; Zhao GJ; Dong N; Sheng ZY
    J Pharmacol Exp Ther; 2010 Dec; 335(3):553-61. PubMed ID: 20843956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Major DQ8-restricted T-cell epitopes for human GAD65 mapped using human CD4, DQA1*0301, DQB1*0302 transgenic IA(null) NOD mice.
    Liu J; Purdy LE; Rabinovitch S; Jevnikar AM; Elliott JF
    Diabetes; 1999 Mar; 48(3):469-77. PubMed ID: 10078545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4(+) T cells from glutamic acid decarboxylase (GAD)65-specific T cell receptor transgenic mice are not diabetogenic and can delay diabetes transfer.
    Tarbell KV; Lee M; Ranheim E; Chao CC; Sanna M; Kim SK; Dickie P; Teyton L; Davis M; McDevitt H
    J Exp Med; 2002 Aug; 196(4):481-92. PubMed ID: 12186840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes in non-obese diabetic mice is not associated with quantitative changes in CD4+ CD25+ Foxp3+ regulatory T cells.
    Mellanby RJ; Thomas D; Phillips JM; Cooke A
    Immunology; 2007 May; 121(1):15-28. PubMed ID: 17428252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GAD-alum treatment induces GAD65-specific CD4+CD25highFOXP3+ cells in type 1 diabetic patients.
    Hjorth M; Axelsson S; Rydén A; Faresjö M; Ludvigsson J; Casas R
    Clin Immunol; 2011 Jan; 138(1):117-26. PubMed ID: 21044870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presence of diabetes-inhibiting, glutamic acid decarboxylase-specific, IL-10-dependent, regulatory T cells in naive nonobese diabetic mice.
    You S; Chen C; Lee WH; Brusko T; Atkinson M; Liu CP
    J Immunol; 2004 Dec; 173(11):6777-85. PubMed ID: 15557171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In Vivo Induction of Functionally Suppressive Induced Regulatory T Cells from CD4+CD25- T Cells Using an Hsp70 Peptide.
    van Herwijnen MJ; van der Zee R; van Eden W; Broere F
    PLoS One; 2015; 10(6):e0128373. PubMed ID: 26107957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy.
    Tian B; Hao J; Zhang Y; Tian L; Yi H; O'Brien TD; Sutherland DE; Hering BJ; Guo Z
    Transplantation; 2009 Jan; 87(2):198-206. PubMed ID: 19155973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamics of pathogenic and suppressor T cells in autoimmune diabetes development.
    Gregori S; Giarratana N; Smiroldo S; Adorini L
    J Immunol; 2003 Oct; 171(8):4040-7. PubMed ID: 14530324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Host-derived CD4+ T cells attenuate stem cell-mediated transfer of autoimmune arthritis in lethally irradiated C57BL/6.g7 mice.
    Rajasekaran N; Wang N; Truong P; Rinderknecht C; Macaubas C; Beilhack GF; Shizuru JA; Mellins ED
    Arthritis Rheum; 2013 Mar; 65(3):681-92. PubMed ID: 23233229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.